Functional assays demonstrated that KRT8 promoted pancreatic cancer cell proliferation, and CCK-8 assays revealed reduced viability upon KRT8 knockdown (Fig. 5H), and increased viability upon KRT8 overexpression (Fig. 5I). The gene discussed is KRT8; the disease is familial pancreatic carcinoma.